mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.8 |